Transcat, Inc. (NASDAQ:TRNS) has earned an average broker rating score of 1.33 (Strong Buy) from the three brokers that cover the stock, Zacks Investment Research reports. One investment analyst has rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company.
Analysts have set a 1-year consensus price target of $27.67 for the company and are forecasting that the company will post $0.17 EPS for the current quarter, according to Zacks. Zacks has also assigned Transcat an industry rank of 20 out of 255 based on the ratings given to its competitors.
TRNS has been the topic of a number of research analyst reports. Zacks Investment Research upgraded Transcat from a “hold” rating to a “buy” rating and set a $22.00 price target on the stock in a research note on Friday, June 15th. Singular Research increased their price target on Transcat from $25.00 to $30.00 and gave the company a “buy” rating in a research note on Tuesday, August 21st.
A number of hedge funds and other institutional investors have recently modified their holdings of TRNS. Bailard Inc. acquired a new position in Transcat in the 2nd quarter valued at $196,000. Spark Investment Management LLC acquired a new position in Transcat in the 2nd quarter valued at $219,000. Hancock Holding Co. acquired a new position in Transcat in the 1st quarter valued at $292,000. ZPR Investment Management grew its holdings in Transcat by 39.2% in the 1st quarter. ZPR Investment Management now owns 20,043 shares of the scientific and technical instruments company’s stock valued at $314,000 after buying an additional 5,648 shares in the last quarter. Finally, Acadian Asset Management LLC grew its holdings in Transcat by 491.7% in the 2nd quarter. Acadian Asset Management LLC now owns 18,485 shares of the scientific and technical instruments company’s stock valued at $350,000 after buying an additional 15,361 shares in the last quarter. 55.26% of the stock is currently owned by hedge funds and other institutional investors.
TRNS traded down $0.20 during trading hours on Monday, reaching $22.10. The company’s stock had a trading volume of 17,300 shares, compared to its average volume of 21,028. Transcat has a 52 week low of $12.00 and a 52 week high of $25.35. The company has a current ratio of 2.04, a quick ratio of 1.33 and a debt-to-equity ratio of 0.37. The stock has a market cap of $159.12 million, a PE ratio of 30.21, a price-to-earnings-growth ratio of 2.85 and a beta of 0.50.
Transcat (NASDAQ:TRNS) last posted its quarterly earnings results on Wednesday, July 25th. The scientific and technical instruments company reported $0.19 earnings per share for the quarter, beating analysts’ consensus estimates of $0.17 by $0.02. Transcat had a return on equity of 11.55% and a net margin of 4.18%. The business had revenue of $36.66 million for the quarter, compared to analysts’ expectations of $38.30 million. equities analysts forecast that Transcat will post 0.97 earnings per share for the current year.
Transcat Company Profile
Transcat, Inc provides calibration and laboratory instrument services in North America and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
See Also: What is the Dividend Aristocrat Index?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.